Retinopatia diabetica

Maria Vittoria CicinelliAlessandra GandolfiDomitilla Mandatori

A cura di Maria Vittoria Cicinelli, Alessandra Gandolfi e Domitilla Mandatori

Maggio
15
2026
Retinopatia diabetica e pathway di STING: un nuovo target terapeutico? - Aberrant STING signalling promotes endothelial dysfunction and neurovascular injury in diabetic retinopathy
A cura di Domitilla Mandatori, Alessandra Gandolfi, Maria Vittoria Cicinelli

Dicembre
12
2025
Validazione prospettica nel mondo reale e valutazione economica dei sistemi di deep learning per il rilevamento della retinopatia diabetica da fotografie del fundus: una revisione sistematica e meta-analisi - Real-World Prospective Validation and Economic Evaluation of Deep Learning-Based Diabetic Retinopathy Detection From Fundus Photographs: A Systematic Review and Meta-analysis
A cura di Maria Vittoria Cicinelli, Domitilla Mandatori, Alessandra Gandolfi

Luglio
11
2025
Oltre il cuore e i reni: l’effetto di empagliflozin sulla microangiopatia retinica - Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes
A cura di Alessandra Gandolfi, Maria Vittoria Cicinelli, Domitilla Mandatori

Marzo
06
2025
Semaglutide e NAION: Reale Rischio o Falsa Paura? - Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Febbraio
06
2025
False friends? - An Update On Ocular Effects Of Anti-Diabetic Medications
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Gennaio
09
2025
Facciamo riposare la nostra intelligenza? - Novel artificial intelligence for diabetic retinopathy and diabetic macular edema: what is new in 2024?
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Dicembre
12
2024
Nuove terapie per il diabete e il rischio di retinopatia diabetica: tra benefici e sfide - Novel agents in the management of diabetes and risk of worsening diabetic retinopathy
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Novembre
14
2024
Progress in Retinal and Eye Research
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Maggio
02
2024
What else can we do to prevent diabetic retinopathy?
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Aprile
04
2024
Association of Metformin With the Development of Age-Related Macular Degeneration
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Marzo
07
2024
EyeArt artificial intelligence analysis of diabetic retinopathy in retinal screening events
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Dicembre
14
2023
ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic Retinopathy
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Novembre
16
2023
Semaglutide and Diabetic Retinopathy Risk in Patients with Type 2 Diabetes Mellitus: A Meta‐Analysis of Randomized Controlled Trials
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Ottobre
19
2023
Analysis of Plasma Metabolic Profile on Ganglion Cell–Inner Plexiform Layer Thickness With Mortality and Common Diseases
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Settembre
21
2023
The Patient Experience with Diabetic Retinopathy: Qualitative Analysis of Patients with Proliferative Diabetic Retinopathy
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Agosto
24
2023
Democratizing healthcare in the Metaverse. How video games can monitor eye conditions using the Vision Performance Index: A pilot study
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Luglio
27
2023
One-field, two-field and five-field handheld retinal imaging compared with standard seven-field Early Treatment Diabetic Retinopathy Study photography for diabetic retinopathy screening
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Giugno
29
2023
Assessment of Parafoveal Diabetic Macular Ischemia on Optical Coherence Tomography Angiography Images to Predict Diabetic Retinal Disease Progression and Visual Acuity Deterioration
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Giugno
01
2023
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy (Review)
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Maggio
04
2023
HIF-1α accumulation in response to transient hypoglycemia may worsen diabetic eye disease
A cura di Roberto Perilli, Maria Vittoria Cicinelli

Aprile
06
2023
Global Prevalence of Diabetic Retinopathy in Pediatric Type 2 Diabetes. A Systematic Review and Meta-analysis
A cura di Roberto Perilli, Maria Vittoria Cicinelli

Aprile
06
2023
Global Prevalence of Diabetic Retinopathy in Pediatric Type 2 Diabetes. A Systematic Review and Meta-analysis
A cura di Roberto Perilli, Maria Vittoria Cicinelli

Marzo
09
2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
A cura di Maria Vittoria Cicinelli, Roberto Perilli

Marzo
09
2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
A cura di Roberto Perilli, Maria Vittoria Cicinelli

Febbraio
09
2023
Global Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Women With Preexisting Diabetes: A Systematic Review and Meta-analysis
A cura di Roberto Perilli, Paolo Fornengo

Gennaio
12
2023
Hyperglycemia Promotes Mitophagy and Thereby Mitigates Hyperglycemia-Induced Damage
A cura di Roberto Perilli, Paolo Fornengo

Dicembre
15
2022
Changes in Visual Impairment due to Diabetic Retinopathy During 1980–2019 Based on Nationwide Register Data
A cura di Roberto Perilli, Paolo Fornengo

Novembre
17
2022
Improving the screening of risk factors in diabetic retinopathy
A cura di Roberto Perilli, Paolo Fornengo

Ottobre
20
2022
Global Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Individuals With Preexisting Diabetes: A Meta-analysis
A cura di Roberto Perilli, Paolo Fornengo

Settembre
22
2022
Association Between Diabetic Retinopathy and Insomnia Risk: A Nationwide Population-Based Study
A cura di Roberto Perilli, Paolo Fornengo

Agosto
25
2022
Biscuit consumption and diabetic retinopathy incidence in adults in the United States
A cura di Roberto Perilli, Paolo Fornengo

Luglio
28
2022
Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - A systematic review and meta-analysis
A cura di Roberto Perilli, Paolo Fornengo

Giugno
30
2022
Efficacy of smartphone-based retinal photography by undergraduate students in screening and early diagnosing diabetic retinopathy
A cura di Roberto Perilli, Paolo Fornengo

Giugno
02
2022
Effects of intensive insulin therapy on the retinal microvasculature in patients with type 2 diabetes mellitus: a prospective observational study
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Maggio
05
2022
Fenofibrate, which reduces risk of sight-threatening diabetic retinopathy in type 2 diabetes, is associated with early narrowing of retinal venules: a FIELD trial substudy
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Aprile
07
2022
Is diabetic retinopathy affected by diabetes type? A retrospective study using electronic medical record data from patients with latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Marzo
10
2022
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Febbraio
10
2022
Costs of Managing Diabetic Macular Edema With Good Visual Acuity With Aflibercept, Laser, or Observation: DRCR Retina Network Protocol V
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Gennaio
13
2022
Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Dicembre
16
2021
Synergy between the pay-for-performance scheme and better physician-patient relationship might reduce the risk of retinopathy in patients with type 2 diabetes
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Novembre
18
2021
Statin reduces the incidence of diabetic retinopathy and its need for intervention: A systematic review and meta-analysis
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Ottobre
21
2021
Awareness of Diabetic Retinopathy: Insight From the National Health and Nutrition Examination Survey
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Settembre
23
2021
Disease burden of diabetes, diabetic retinopathy and their future projections in the UK: cross-sectional analyses of a primary care database
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Agosto
26
2021
Application of 5G Technology to Conduct Real-Time Teleretinal Laser Photocoagulation for the Treatment of Diabetic Retinopathy
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Luglio
29
2021
Therapeutic of Candesartan and Music Therapy in Diabetic Retinopathy with Depression in Rats
A cura di Massimo Porta, Roberto Perilli, Paolo Fornengo

Luglio
01
2021
Cardiovascular Adverse Events With Intravitreal Anti–Vascular Endothelial Growth Factor Drugs A Systematic Review and Meta-analysis of Randomized Clinical Trials
A cura di Roberto Perilli, Massimo Porta, Paolo Fornengo

Giugno
03
2021
Relationship between Intrinsically Photosensitive Ganglion Cell Function and Circadian Regulation in Diabetic Retinopathy
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Aprile
08
2021
Predicting the risk of developing diabetic retinopathy using deep learning
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Marzo
11
2021
Association of Metformin Use With Age-Related Macular Degeneration A Case-Control Study
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Gennaio
14
2021
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to Vision 2020: The Right to Sight: an analysis for the Global Burden of Disease study
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Dicembre
17
2020
Frequent physical activity is associated with reduced risk of severe diabetic retinopathy in type 1 diabetes
A cura di Massimo Porta, Roberto Perilli, Paolo Fornengo

Ottobre
22
2020
Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Settembre
24
2020
Expectations and fears of patients with diabetes and macular edema treated by intravitreal injections
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Agosto
01
2019
Worsening of diabetic retinopathy with rapid improvement in systemic glucose control
A cura di Paolo Fornengo, Massimo Porta

Luglio
04
2019
Identification of barriers, facilitators and system-based implementation strategies to increase teleophthalmology use for diabetic eye screening in a rural US primary care clinic: a qualitative study
A cura di Roberto Perilli, Paolo Fornengo, Massimo Porta

Giugno
06
2019
Single herbal medicine for diabetic retinopathy
A cura di Paolo Fornengo, Massimo Porta

Maggio
09
2019
Non-mydriatic Fundus Retinography in Screening for Diabetic Retinopathy: Agreement Between Family Physicians, General Ophthalmologists, and a Retinal Specialist
A cura di Roberto Perilli, Massimo Porta, Paolo Fornengo

Aprile
11
2019
Impact of Age of Onset, Puberty, and Glycemic Control Followed From Diagnosis on Incidence of Retinopathy in Type 1 Diabetes: the VISS Study
A cura di Paolo Fornengo, Massimo Porta

Marzo
14
2019
Early Response to Anti–Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T
A cura di Roberto Perilli, Massimo Porta, Paolo Fornengo

Febbraio
14
2019
Association Of Statin Therapy With Prevention Of Vision-Threating Diabetic Retinopathy
A cura di Paolo Fornengo, Massimo Porta

Gennaio
17
2019
Real-world outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States
A cura di Paolo Fornengo, Roberto Perilli, Massimo Porta

Dicembre
20
2018
The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up
A cura di Massimo Porta, Paolo Fornengo

Novembre
22
2018
Association of intravitreal injections with blood pressure increase. The following excitement and anxiety response under intravitreal injection study
A cura di Paolo Fornengo, Massimo Porta

Ottobre
25
2018
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
A cura di Gianni Virgili, Carla Donati, Elisa Marziali, Lidia Vicchio

Settembre
27
2018
Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning
A cura di Massimo Porta

Agosto
02
2018
Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1
A cura di Elena Beltramo, Aurora Mazzeo, Massimo Porta

Luglio
05
2018
Sirt 1: A Guardian of the Development of Diabetic Retinopathy
A cura di Massimo Porta, Elio Striglia

Giugno
07
2018
Association Between Vessel Density and Visual Acuity in Patients With Diabetic Retinopathy and Poorly Controlled Type 1 Diabetes
A cura di Rosangela Lattanzio, Francesco Bandello

Maggio
10
2018
Lack of Longitudinal Association Between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD Eye Study
A cura di Massimo Porta

Aprile
12
2018
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial
A cura di Gianni Virgili, Elisa Marziali, Lidia Vicchio, Carla Donati

Marzo
15
2018
Contrast sensitivity to spatial gratings in moderate and dim light conditions in patients with diabetes in the absence of diabetic retinopathy
A cura di Giuseppe Picca, Massimo Porta

Febbraio
15
2018
Macular thickness profile and diabetic retinopathy: the Singapore Epidemiology of Eye Disease study
A cura di Francesco Bandello, Rosangela Lattanzio, Luigi Capone

Gennaio
18
2018
AAV-CRISPR/Cas9–Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro
A cura di Aurora Mazzeo, Elena Beltramo, Massimo Porta

Dicembre
21
2017
Are we making good use of our public resources? The false-positive rate of screening by fundus photography for diabetic macular oedema
A cura di Massimo Porta

Novembre
23
2017
The Pericytic Phenotype of Adipose Tissue-derived Stromal Cells is Promoted by NOTCH2
A cura di Elena Beltramo, Aurora Mazzeo, Massimo Porta

Ottobre
26
2017
High Glucose Induces Mitochondrial Dysfunction in Retinal Müller Cells: Implications for Diabetic Retinopathy
A cura di Massimo Porta

Settembre
28
2017
Vascular Safety of Ranibizumab in Patients With Diabetic Macular Edema. A Pooled Analysis of Patient-Level Data From Randomized Clinical Trials
A cura di Massimo Porta

Agosto
31
2017
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
A cura di Gianni Virgili, Ersilia Lucenteforte, Mariacristina Parravano

Agosto
03
2017
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY)
A cura di Francesco Bandello, Rosangela Lattanzio, Eleonora Corbelli

Luglio
06
2017
Cognitive function may be a predictor of retinopathy progression in patients with type 2 diabetes
A cura di Marina Trento, Massimo Porta

Giugno
08
2017
Incentives in Diabetic Eye Assessment by Screening (IDEAS) trial: a three-armed randomised controlled trial of financial incentives
A cura di Massimo Porta

Maggio
11
2017
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes
A cura di Massimo Porta

Aprile
13
2017
Diabetic Retinopathy: A Position Statement by the American Diabetes Association
A cura di Massimo Porta

Marzo
16
2017
The English National Screening Programme for diabetic retinopathy 2003–2016
A cura di Massimo Porta

Febbraio
16
2017
Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies
A cura di Massimo Porta

Gennaio
19
2017
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs
A cura di Massimo Porta

Dicembre
22
2016
Impact of Diabetic Retinopathy on Vulnerability of Atherosclerotic Coronary Plaque and Incidence of Acute Coronary Syndrome
A cura di Massimo Porta

Novembre
24
2016
Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010
A cura di Massimo Porta

Ottobre
27
2016
Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trial
A cura di Massimo Porta, Marina Trento

Settembre
29
2016
Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy
A cura di Massimo Porta

Settembre
01
2016
Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema Report From RESTORE, RIDE, and RISE Trials
A cura di Massimo Porta, Marina Trento

Agosto
04
2016
Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and Retinopathy
A cura di Massimo Porta

Luglio
07
2016
Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study
A cura di Massimo Porta

Giugno
09
2016
Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study
A cura di Giuseppe Picca, Massimo Porta

Maggio
19
2016
Evaluation of Automated Teleretinal Screening Program for Diabetic Retinopathy
A cura di Massimo Porta, Gianni Virgili, Carla Donati

Aprile
21
2016
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema. Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
A cura di Massimo Porta, Monica Varano

Marzo
24
2016
Topical Administration of GLP-1Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes
A cura di Massimo Porta, Paolo Fornengo

Febbraio
25
2016
Variation in SLC19A3 and protection from microvascular damage in type 1 diabetes
A cura di Massimo Porta

Gennaio
28
2016
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy. A Randomized Clinical Trial
A cura di Massimo Porta, Lucia Scoccianti, Giacomo Panozzo

Dicembre
31
2015
Moderate consumption of white and fortified wine is associated with reduced odds of diabetic retinopathy
A cura di Massimo Porta, Giuseppe Picca

Dicembre
03
2015
Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion
A cura di Massimo Porta, Paolo Fornengo

Novembre
05
2015
The cross-sectional associations between sense of coherence and diabetic microvascular complications, glycaemic control, and patients' conceptions of type 1 diabetes
A cura di Marina Trento, Massimo Porta

Ottobre
08
2015
Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs
A cura di Massimo Porta

Agosto
13
2015
Hyperhexosemia-Induced Retinal Vascular Pathology in a Novel Primate Model of Diabetic Retinopathy
A cura di Massimo Porta

Luglio
16
2015
Severe diabetic retinal disease and dementia risk in type 2 diabetes
A cura di Lorenzo Borio, Massimo Porta

Giugno
18
2015
Intensive Diabetes Therapy and Ocular Surgery in Type 1 Diabetes
A cura di Lorenzo Borio, Massimo Porta

Maggio
21
2015
Impact of socioeconomic deprivation on the development of diabetic retinopathy: a population-based, cross-sectional and longitudinal study over 12 years
A cura di Massimo Porta, Lorenzo Borio

Aprile
23
2015
Aflibercept, Bevacizumab or Ranibizumab for Diabetic Macular Edema
A cura di Massimo Porta, Lorenzo Borio

Marzo
26
2015
Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis
A cura di Massimo Porta, Lorenzo Borio

Febbraio
26
2015
Blood pressure control for diabetic retinopathy
A cura di Massimo Porta, Lorenzo Borio

Febbraio
10
2015
Chirurgia bariatrica e retinopatia diabetica: quando la Review supera la Metanalisi.
A cura di Massimo Porta, Lorenzo Borio

Gennaio
30
2015
Analisi di costo-efficacia dei trattamenti per l’edema maculare diabetico
A cura di Massimo Porta, Lorenzo Borio

Gennaio
30
2015
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus (Review)
A cura di Massimo Porta

Gennaio
30
2015
Gli anni di malattia “pre-puberali” contribuiscono in ritardo ma a pieno titolo allo sviluppo della retinopatia diabetica
A cura di Massimo Porta, Lorenzo Borio

Gennaio
30
2015
Statin use and risk for cataract: a nested case-control study of 2 populations in Canada and the United States
A cura di Massimo Porta, Lorenzo Borio

Siditalia
Società Italiana di Diabetologia e delle Malattie del Metabolismo Ente del Terzo Settore
P. IVA 04394411005 C.F 80101700013

CONTATTI

+39 06.44240967
siditalia@siditalia.it
Via Pisa, 21 00162 Roma
World Obesity
Logic Solution
Copyright © 2023 SID ITALIA. Tutti i diritti riservati.